| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International, plc | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 01, 2024 | Option Exercise | $26.74 | 2,260 | 60,432 | 22,053 | Sep 04, 2024, 08:51 PM | |
| KNSA | Kiniksa Pharmaceuticals International, plc | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 02, 2024 | Option Exercise | $26.74 | 956 | 25,563 | 22,958 | Sep 04, 2024, 08:51 PM | |
| KNSA | Kiniksa Pharmaceuticals International, plc | Ragosa Mark | CHIEF FINANCIAL OFFICER | Jul 23, 2024 | Sale | $24.79 | 24,248 | 601,108 | 19,253 | Jul 25, 2024, 04:32 PM | |
| KNSA | Kiniksa Pharmaceuticals International, plc | Ragosa Mark | CHIEF FINANCIAL OFFICER | Jul 23, 2024 | Option Exercise | $11.10 | 24,248 | 269,153 | 43,501 | Jul 25, 2024, 04:32 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Apr 26, 2024 | Option Exercise | $17.88 | 509 | 9,101 | 19,253 | Apr 30, 2024, 04:35 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Apr 08, 2024 | Option Exercise | $17.90 | 791 | 14,159 | 18,771 | Apr 08, 2024, 05:20 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Apr 01, 2024 | Option Exercise | $19.70 | 514 | 10,126 | 16,868 | Apr 03, 2024, 05:25 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Jan 03, 2024 | Sale | $20.00 | 12,000 | 240,000 | 15,632 | Jan 04, 2024, 04:30 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Jan 03, 2024 | Option Exercise | $8.83 | 12,000 | 105,960 | 27,632 | Jan 04, 2024, 04:30 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 01, 2023 | Option Exercise | $17.76 | 791 | 14,048 | 14,318 | Sep 06, 2023, 07:06 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 02, 2023 | Option Exercise | $17.76 | 547 | 9,715 | 15,632 | Sep 06, 2023, 07:06 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Apr 26, 2023 | Option Exercise | $11.15 | 291 | 3,245 | 12,414 | Apr 28, 2023, 04:15 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Apr 10, 2023 | Option Exercise | $10.71 | 791 | 8,472 | 11,715 | Apr 11, 2023, 05:04 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Mar 20, 2023 | Option Exercise | $11.12 | 634 | 7,050 | 9,811 | Mar 20, 2023, 05:14 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Mar 16, 2023 | Option Exercise | $11.46 | 256 | 2,934 | 8,287 | Mar 20, 2023, 05:14 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 02, 2022 | Option Exercise | $11.44 | 547 | 6,258 | 7,671 | Sep 06, 2022, 04:10 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Apr 26, 2022 | Option Exercise | $9.99 | 282 | 2,817 | 6,357 | Apr 28, 2022, 04:31 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Mar 21, 2022 | Option Exercise | $10.98 | 1,047 | 11,496 | 5,648 | Mar 23, 2022, 04:30 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | Chief Financial Officer | Mar 16, 2022 | Option Exercise | $10.13 | 303 | 3,069 | 3,676 | Mar 18, 2022, 04:38 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | Interim CFO | Dec 31, 2020 | Option Exercise | $17.67 | 1,297 | 22,918 | 3,107 | Jan 05, 2021, 05:07 PM |
Menu